|
|
Post by jckrdu on Jan 29, 2015 20:03:45 GMT
I decided to hold off. If it goes to $.29-$.32 I will be forced in but right now I am all tied up in other companies... Some heavy volume today with this sell off. No position in ONCS, but I intend to move $$$ back in here before the combo trial results are announced.
Part of me feels like the CEO is going to do a reverse split to reduce the share count and get uplisted before those combo results are announced. I'm a little hesitant to buy back in thinking that news is coming.
|
|
|
|
Post by actcfan on Feb 10, 2015 18:13:25 GMT
The chart isn't looking too good here right now. Without some news to help bring some new capital in (which isn't likely in the immediate future IMO), I could easily see this sitting in the mid $.30's for quite some time. Because of this, I sold off 25% of my position at $.395 yesterday (13% realized loss). I'm still very excited about the potential here. It seems incredibly likely that the combo trial with Merck's Keytruda will show Merck what they're wanting to see. If/When this occurs, I'll likely double down on my current position and trade the newly purchased shares in 5 equal blocks each time it goes up 20 cents (maybe/hopefully we're talking dollars by then if they get their capital structure in order and get listed on a reputable exchange). The cult following this company has seems to make it a traders paradise (like ACTC/OCAT has been and will continue to be). I need to make sure to take advantage of the volatile swings this time! I hear ya. Still frustrated for not selling some at $.65 back in December. I think the combo trial will show very good results. I also think that it won't take too long to have data since according to Furbush who went to the symposium the other day, it is only going to be a 10 patient study. In the past I would probably just have held on added more, as I do think ONCS is onto something. There are just too many other opportunities right now that I don't want to miss out on instead of sitting and waiting with ONCS. I'll likely start buying after I trade some of my other stocks and as we get closer to May or if it drops into the low $.30s. The current prices are a bargain. I can't imagine the pps going into the $.20s, but you never know. That would really be a steal in my opinion. Dr. Pierce is apparently going to be presenting unpublished data at a conference in May. Not sure what it will be. Seems to soon to be P2b interim data or H&N. Jham, You mention ONCS presenting in May, do you know if they are presenting at ASCO? Thanks |
|
